Director, Norris Cotton Cancer Center
Mark A. Israel, MD
Director, Norris Cotton Cancer Center
Mark A. Israel received his BA from Hamilton College in 1968 and his MD from Albert Einstein College of Medicine, Yeshiva University in 1973. After an internship and residency training in pediatrics at Boston Children's Hospital Medical Center, he joined the research effort of the National Institutes of Health (NIH) in 1975, first with the NIAID Laboratory of Biology of Viruses and thereafter with the DNA Recombinant Research Unit of NIAID, NIH.
Moving to the NIH National Cancer Institute, Dr. Israel worked with the Pediatric Branch, and in 1984 became head of the Molecular Genetics Section of the Pediatric Branch. In 1989, he accepted a joint appointment with the UCSF School of Medicine as Professor of Neurological Surgery and Pediatrics, where he is also Director of the Preuss Laboratory of the UCSF Brain Tumor Research Center, a member of the Molecular Medicine Program and Program in Developmental Biology, and a member of the Biomedical Science Program. He has an international reputation for both his research and his educational efforts in the mentorship of postdoctoral fellows, and from 1993 to 1996, he was co-investigator in the gene therapy trial, "Gene Therapy for Treatment of Malignant Brain Tumors with in vivo Tumor Transduction with the Herpes Simplex Thymidine Kinase Gene/Ganciclovir System." Dr. Israel is currently also a member of the NIH NCI Board of Scientific Counselors.
